1. Home
  2. WKC vs CAPR Comparison

WKC vs CAPR Comparison

Compare WKC & CAPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo World Kinect Corporation

WKC

World Kinect Corporation

HOLD

Current Price

$26.46

Market Cap

1.4B

Sector

Energy

ML Signal

HOLD

Logo Capricor Therapeutics Inc.

CAPR

Capricor Therapeutics Inc.

HOLD

Current Price

$23.17

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WKC
CAPR
Founded
1984
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WKC
CAPR
Price
$26.46
$23.17
Analyst Decision
Hold
Strong Buy
Analyst Count
4
8
Target Price
$28.75
$41.38
AVG Volume (30 Days)
922.2K
1.3M
Earning Date
02-19-2026
11-10-2025
Dividend Yield
3.03%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$37,648,100,000.00
$11,130,509.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.13
$16,329.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.71
$4.30
52 Week High
$31.54
$40.37

Technical Indicators

Market Signals
Indicator
WKC
CAPR
Relative Strength Index (RSI) 56.26 44.90
Support Level $25.84 $23.52
Resistance Level $28.16 $24.74
Average True Range (ATR) 0.83 1.58
MACD -0.03 -0.76
Stochastic Oscillator 53.55 2.92

Price Performance

Historical Comparison
WKC
CAPR

About WKC World Kinect Corporation

World Kinect Corp is an energy management company involved in providing supply fulfillment, energy procurement advisory services, and transaction and payment management solutions to commercial and industrial customers. It sells and delivers liquid fuels, natural gas, electricity, renewable energy, and other sustainability solutions. The company operates in three reportable segments consisting of aviation, land, and marine. The company earns the majority of its revenue from the Aviation segment.

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

Share on Social Networks: